COVID-19 vaccine hesitancy before marketing and its related influencing factors
HUO Da1,2,3, ZHOU Tao4, WANG Chao5, MAO Zhe-fei1,2, ZHOU Jie1,2
1. Institute of Psychology, Chinese Academy of Sciences, Beijing 100101, China; 2. Department of Psychology, University of Chinese Academy of Sciences, Beijing 100049, China; 3. Institute for Infectious Disease and Endemic Disease Control, Beijing Research Center for Preventive Medicine, Beijing Center for Disease Prevention and Control, Beijing 100013, China; 4. Institute for Immunization and Prevention, Beijing Research Center for Preventive Medicine, Beijing Center for Disease Prevention and Control, Beijing 100013, China; 5. Institute for Information and Statistics, Beijing Research Center for Preventive Medicine, Beijing Center for Disease Prevention and Control, Beijing 100013, China
Abstract：Objective To investigate the hesitancy of COVID-19 vaccination before marketing and its related determinants so as to provide a scientific basis for specific countermeasures of vaccine hesitancy in the early stage. Methods An Internet survey with a self-designed questionnaire was conducted to make comparisons between the fully accepted and the hesitant in the aspects of social demographic profile, knowledge about COVID-19, general knowledge about COVID-19 vaccine, and dimensions like confidence, complacency and convenience. Univariate and multivariate logistic regression analyses were employed to analyze the related factors influencing COVID-19 vaccine hesitancy. Results Of 406 valid questionnaires received, the fully accepted, the hesitant and the fully refused were 171 (42.1%), 211 (52.0%) and 24 (5.9%), respectively. Multivariate logistic regressionanalysis showed that factors bringing down the vaccine hesitancy were the health status of respondents(having a chronic disease vs. being healthy, OR=4.415, 95%CI:1.176-16.574), convenience of vaccination time (OR=2.262, 95%CI:1.625-3.147), confidence of the vaccine safety (OR=2.188, 95%CI:1.493-3.206), vaccination of health care providers (OR=1.775, 95%CI:1.174-2.682), health care providers’ neutral attitude towards the vaccine (OR=1.635, 95%CI:1.139-2.349), propaganda and advertisement (OR=1.613, 95%CI:1.102-2.361), and convenience of travel after vaccination (OR=1.400, 95%CI:1.034-1.897), while the factor that enhanced the vaccine hesitancy was perception of low infection risk (OR=0.630, 95%CI:0.477-0.832). Conclusion Enhancing publicity of the vaccine among healthy people, extending service hours of vaccination sites, emphasizing safety of the vaccine, improving the vaccine coverage of health care providers, publicizing through a variety of media, launching policies of travel convenience after vaccination, and stressing the risk of infection at present are possible countermeasures to COVID-19 vaccine hesitancy.
霍达, 周涛, 王超, 毛浙飞, 周洁. 新型冠状病毒肺炎疫苗上市前疫苗犹豫情况及相关影响因素研究[J]. 实用预防医学, 2022, 29(1): 27-31.
HUO Da, ZHOU Tao, WANG Chao, MAO Zhe-fei, ZHOU Jie. COVID-19 vaccine hesitancy before marketing and its related influencing factors. , 2022, 29(1): 27-31.
[1] World Health Organization. SAGE working group dealing with vaccine hesitancy (March 2012 to November 2014)[EB/OL]. (2020-04-08)[2020-04-14]. https://www.who.int/immunization/sage/sage_wg_vaccine_hesitancy_apr12/en/. [2] MacDonald NE,SAGE Working Group on Vaccine Hesitancy. Vaccine hesitancy: definition, scope and determinants[J]. Vaccine, 2015, 33(34):4161-4164. [3] World Health Organization. Ten threats to global health in 2019[EB/OL].(2019-01-10) [2020-04-14]. https://www.who.int/news-room/feature-stories/ten-threats-to-global-health-in-2019. [4] Larson HJ, Jarrett C, Eckersberger E, et al. Understanding vaccine hesitancy around vaccines and vaccination from a global perspective: a systematic review of published literature, 2007-2012[J]. Vaccine, 2014, 32(19):2150-2159. [5] Paules CI, Marston HD, Fauci AS. Measles in 2019-going backward[J]. N Engl J Med, 2019, 380(23):2185-2187. [6] 李亚飞, 马浩淞, 李瑞仙, 等. 厦门市男大学生HPV疫苗认知和接种意愿及影响因素[J]. 中国学校卫生, 2019, 40(12):1880-1883. [7] 唐智敏, 余文周, 刘燕敏, 等. 儿童父母肠道病毒71型灭活疫苗犹豫及其影响因素分析[J]. 中国疫苗和免疫, 2018, 24(3):334-338. [8] Kassianos G, Kuchar E, Nitsch-Osuch A, et al. Motors of influenza vaccination uptake and vaccination advocacy in healthcare workers: a comparative study in six European countries[J]. Vaccine, 2018, 36(44):6546-6552. [9] Opel DJ, Mangione-Smith R, Taylor JA, et al. Development of a survey to identify vaccine-hesitant parents: the parent attitudes about childhood vaccines survey[J]. Hum Vaccine, 2011, 7(4):419-425. [10] 唐智敏. 儿童父母对肠道病毒71型灭活疫苗犹豫调查问卷开发及初步应用[D]. 北京: 中国疾病预防控制中心, 2018. [11] 方任飞, 马彦, 吴疆, 等. 北京市老年人免费流感疫苗接种率及认知影响因素调查分析[J]. 中国全科医学, 2014, 17(12):1403-1406. [12] 中华预防医学会.预防接种知情告知专家共识(上)[J].实用预防医学, 2021, 28(4):385-391. [13] 郑阳,王小莉,霍达,等.北京市新发地市场新冠肺炎暴发疫情发现与处置[J]. 国际病毒学杂志, 2020,27(6):444-447. [14] 马春娜, 吴双胜, 孙瑛, 等. 2020年1—7月北京市不同阶段新型冠状病毒肺炎疫情特征分析[J]. 国际病毒学杂志, 2020, 27(6):8-14. [15] Kudo R,Sekine M,Yamaguchi M,et al. Internet survey of awareness and behavior related to HPV vaccination in Japan[J]. Vaccine (Basel), 2021, 9(2):87.
2022, Vol. 29 
